Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Primary Lymphoid Organs01:16

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal methylated ctDNA increases predict immunotherapy progression across solid tumors.

The journal of liquid biopsy·2026
Same author

Cryoanalgesia in Thoracic Surgery.

Innovations (Philadelphia, Pa.)·2026
Same author

Reducing treatment time and number of nerves treated fails to improve cryoanalgesia outcomes.

JTCVS open·2026
Same author

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Heart failure with reduced ejection fraction: A systematic review of clinical practice guidelines and recommendations.

European heart journal. Quality of care & clinical outcomes·2026
Same author

Reply: Molecular prognostication, response validation, and bronchoscopic intervention: The next frontiers of radiofrequency ablation.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

A Health Tracking Application Leads to An Avid Cyclist Being Diagnosed with ALCAPA at 52 years old, Warranting a Takeuchi Repair.

The Annals of thoracic surgery·2026
Same journal

Impact of preoperative and postoperative modern guideline-directed medical therapy on survival following coronary artery bypass grafting.

The Annals of thoracic surgery·2026
Same journal

Does prior percutaneous coronary revascularization negatively affect the outcomes of subsequent coronary artery bypass grafting?

The Annals of thoracic surgery·2026
Same journal

Lymph Node Dissection and Chylothorax - Balancing Oncologic Benefit Against Morbidity.

The Annals of thoracic surgery·2026
Same journal

Preserved Antegrade Pulmonary Blood Flow in Bidirectional Glenn: Outcomes and Considerations for Staged Palliation.

The Annals of thoracic surgery·2026
Same journal

Domo Arigato, Mr. Roboto.

The Annals of thoracic surgery·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Thymomas and extrathymic cancers.

Benny Weksler1, Katie S Nason, Daniel Mackey

  • 1Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. wekslergb@upmc.edu

The Annals of Thoracic Surgery
|October 4, 2011
PubMed
Summary
This summary is machine-generated.

Patients with thymoma have a significantly higher risk of developing extrathymic cancers, including lymphomas and lung cancer. This increased incidence of extrathymic neoplasia occurs both before and after a thymoma diagnosis.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Area of Science:

  • Oncology
  • Epidemiology
  • Cancer Research

Background:

  • Thymoma patients may exhibit a predisposition to extrathymic neoplasia.
  • Understanding the lifetime risk and incidence of extrathymic neoplasms in thymoma patients is crucial.
  • This study evaluated extrathymic neoplasms diagnosed before or after thymoma diagnosis.

Purpose of the Study:

  • To determine the incidence of extrathymic neoplasia in patients diagnosed with thymoma.
  • To compare the risk of extrathymic cancers in thymoma patients versus the general population.
  • To identify risk factors associated with extrathymic cancer development in thymoma patients.

Main Methods:

  • Utilized the Surveillance, Epidemiology, and End Results (SEER) cancer database.
  • Identified patients with thymoma and extrathymic neoplasms, collecting demographic and treatment data.
  • Calculated age-adjusted incidence rates and compared them to the general population, calculating standardized incidence ratios.

Main Results:

  • 14.1% of 2,171 thymoma patients had extrathymic primary cancers.
  • The incidence of extrathymic cancers in thymoma patients was significantly higher (8,224 per 100,000) than in the general population (459 per 100,000).
  • Increased risk observed for lymphomas, leukemias, esophageal, and lung cancers; age, survival, and male sex were significant risk factors.

Conclusions:

  • Patients with thymoma demonstrate a significantly elevated incidence of extrathymic neoplasia.
  • Extrathymic cancers occur both prior to and following a thymoma diagnosis.
  • The findings highlight a critical need for monitoring extrathymic cancer risk in thymoma survivors.